ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 35 filers reported holding ASTRIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,184,422 | -10.4% | 1,901,397 | 0.0% | 1.71% | -23.6% |
Q2 2023 | $15,838,637 | -37.4% | 1,901,397 | 0.0% | 2.23% | -48.7% |
Q1 2023 | $25,288,580 | -10.7% | 1,901,397 | 0.0% | 4.35% | -3.2% |
Q4 2022 | $28,311,801 | +243.5% | 1,901,397 | +108.5% | 4.49% | +209.9% |
Q3 2022 | $8,242,000 | +201.4% | 911,736 | 0.0% | 1.45% | +131.5% |
Q2 2022 | $2,735,000 | -55.3% | 911,736 | 0.0% | 0.63% | -56.7% |
Q1 2022 | $6,118,000 | +24.5% | 911,736 | 0.0% | 1.45% | -10.7% |
Q4 2021 | $4,914,000 | -39.0% | 911,736 | 0.0% | 1.62% | -44.7% |
Q3 2021 | $8,060,000 | – | 911,736 | – | 2.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 911,736 | $8,060,000 | 2.93% |
VR Adviser, LLC | 538,999 | $4,765,000 | 0.61% |
COMMODORE CAPITAL LP | 239,270 | $2,115,000 | 0.56% |
Perceptive Advisors | 1,959,652 | $17,323,000 | 0.25% |
Cormorant Asset Management, LP | 552,903 | $4,888,000 | 0.20% |
RA Capital Management | 1,262,193 | $11,158,000 | 0.16% |
Soleus Capital Management, L.P. | 112,499 | $994,000 | 0.16% |
ArchPoint Investors | 28,247 | $250,000 | 0.08% |
Ikarian Capital, LLC | 87,580 | $775,000 | 0.06% |
Old Well Partners, LLC | 12,116 | $107,000 | 0.06% |